March 3, 2017
Dr. Masayo TAKAHASHI, Project Leader, Laboratory for Retinal Regeneration, RIKEN Center for Developmental Biology, whose work led the world first clinical trial to use induced pluripotent stem (iPS) cells in humans visited RIKEN Singapore with other researchers after their attendance at symposium in Singapore.
